We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Trimetrexate in malignant mesothelioma: A Cancer and Leukemia Group B Phase II study.
- Authors
Vogelzang, N J; Weissman, L B; Herndon, J E, 2nd; Antman, K H; Cooper, M R; Corson, J M; Green, M R
- Abstract
Folic acid antagonists are reported to have activity against mesothelioma. The Cancer and Leukemia Group B (CALGB) undertook this phase II study of the new antifolate, trimetrexate (TMTX), to evaluate its response rate and toxicity in chemotherapy-naive patients with malignant mesothelioma.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Vol 12, Issue 7, p1436
- ISSN
0732-183X
- Publication type
Journal Article
- DOI
10.1200/JCO.1994.12.7.1436